{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:54:59Z","timestamp":1792479299112,"version":"4.5.0"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Despite being recommended by clinical guidelines, substantial concerns remain regarding the use of high-sensitivity cardiac troponin assays and whether it is associated with increased resource use, myocardial infarction (MI) or myocardial injury diagnoses, and procedural rates.<\/jats:p><\/jats:sec>Objective<\/jats:title>To characterize the association of reporting high-sensitivity cardiac troponin T (hs-cTnT) to the lowest limit of quantification vs conventional troponin reporting with clinical outcomes.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study used a historically controlled baseline and follow-up design to compare clinical outcomes after changing hs-cTnT reporting to the lowest limit of quantification. All patients aged 18 years or older presenting to any public emergency department (ED) in the state of South Australia between February 1, 2020, and February 28, 2021, who had an hs-cTnT test in the 6 months before and after the change in troponin reporting practice were included. Outcomes were assessed after adjusting for patient characteristics using inverse probability treatment weighting. The data analysis was performed between May 1, 2022, and July 27, 2023.<\/jats:p><\/jats:sec>Exposure<\/jats:title>hs-cTcnT reporting.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcomes were frequency of diagnosed MI, coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft (CABG); hospital length of stay; and ED discharge rate as measured using time-to-event Cox regression models. The secondary outcome was the composite 12-month event rate of all-cause mortality, MI, and myocardial injury.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 40\u202f921 patients were included, of whom 20\u202f206 were included in the unmasked hs-cTnT reporting group (median [IQR] age, 62.0 [46.0-77.0]; 10 120 females [50.1%]) and 20\u202f715 were included in the conventional troponin reporting group (median [IQR] age, 63.0 [47.0-77.0] years; 10 752 males [51.9%]). Unmasked hs-cTnT reporting was associated with higher ED discharge rates (45.2% vs 39.0%; P<\/jats:italic>\u2009&amp;lt;\u2009.001) and a shorter median hospital length of stay (7.68 [IQR, 4.32-46.80] hours vs 7.92 [IQR, 4.56-49.92] hours; P<\/jats:italic>\u2009&amp;lt;\u2009.001). There was no difference in diagnosis of MI, coronary angiography, percutaneous coronary intervention, or coronary artery bypass graft. The composite of all-cause mortality, MI, and myocardial injury at 12 months was similar (adjusted hazard ratio, 0.95; 95% CI, 0.90-1.01; P<\/jats:italic>\u2009=\u2009.09).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This cohort study found that unrestricted reporting of hs-cTnT results to the lowest limit of quantification was not associated with an increase in the diagnosis of MI, invasive coronary procedures, or harm at 12 months but may be associated with improved hospital resource use.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.38541","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T15:17:16Z","timestamp":1729005436000},"page":"e2438541","source":"Crossref","is-referenced-by-count":6,"title":["High-Sensitivity Cardiac Troponin T Reporting, Clinical Outcomes, and Health Care Resource Use"],"prefix":"10.1001","volume":"7","author":[{"given":"Mau T.","family":"Nguyen","sequence":"first","affiliation":[{"name":"Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia"},{"name":"Department of Emergency Medicine, The Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia"},{"name":"Adelaide Medical School, The University of Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lambrakis","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia"},{"name":"Department of Medicine, Cardiology and Critical Care, Southern Adelaide Local Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Lehman","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia"},{"name":"Department of Medicine, Cardiology and Critical Care, Southern Adelaide Local Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Haustead","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia"},{"name":"Adelaide Medical School, The University of Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Psaltis","sequence":"additional","affiliation":[{"name":"Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia"},{"name":"Department of Emergency Medicine, The Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia"},{"name":"Adelaide Medical School, The University of Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek P.","family":"Chew","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia"},{"name":"Department of Medicine, Cardiology and Critical Care, Southern Adelaide Local Health Network, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Papendick","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia"},{"name":"Adelaide Medical School, The University of Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,15]]},"reference":[{"issue":"18","key":"zoi241116r1","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"zoi241116r2","first-page":"e368","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"issue":"14","key":"zoi241116r3","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J"},{"key":"zoi241116r4","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2021.42","article-title":"Type 2 MI and myocardial injury in the era of high-sensitivity troponin.","volume":"17","author":"Rafiudeen","year":"2022","journal-title":"Eur Cardiol"},{"issue":"19","key":"zoi241116r5","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.119.042891","article-title":"A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT).","volume":"140","author":"Chew","year":"2019","journal-title":"Circulation"},{"issue":"23","key":"zoi241116r6","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.119.045480","article-title":"Implementing high-sensitivity cardiac troponin T in a US regional healthcare system.","volume":"141","author":"Sandoval","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"zoi241116r7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.annemergmed.2020.06.047","article-title":"Diagnostic reclassification by a high-sensitivity cardiac troponin assay.","volume":"76","author":"Mumma","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"25","key":"zoi241116r8","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.jacc.2021.04.050","article-title":"Clinical impact of high-sensitivity cardiac troponin T implementation in the community.","volume":"77","author":"Ola","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"44","key":"zoi241116r9","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1093\/eurheartj\/ehw232","article-title":"Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction.","volume":"37","author":"Twerenbold","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"zoi241116r10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.annemergmed.2018.11.039","article-title":"A rule-out strategy based on high-sensitivity troponin and HEART score reduces hospital admissions.","volume":"73","author":"Ljung","year":"2019","journal-title":"Ann Emerg Med"},{"key":"zoi241116r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101011","article-title":"Machine-learning for phenotyping and prognostication of myocardial infarction and injury in suspected acute coronary syndrome.","author":"Khan","journal-title":"JACC Adv"},{"issue":"3","key":"zoi241116r12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1373\/clinchem.2018.298059","article-title":"Global adoption of high-sensitivity cardiac troponins and the universal definition of myocardial infarction.","volume":"65","author":"Anand","year":"2019","journal-title":"Clin Chem"},{"issue":"25","key":"zoi241116r13","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1016\/j.jacc.2021.04.049","article-title":"Downstream cascades of care following high-sensitivity troponin test implementation.","volume":"77","author":"Ganguli","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"zoi241116r14","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.jacc.2018.03.515","article-title":"High-sensitivity troponins and outcomes after myocardial infarction.","volume":"71","author":"Odqvist","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"zoi241116r15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.amjmed.2012.07.015","article-title":"Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis.","volume":"125","author":"Reichlin","year":"2012","journal-title":"Am J Med"},{"issue":"5","key":"zoi241116r16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/CIRCOUTCOMES.115.002488","article-title":"Randomized comparison of high-sensitivity troponin reporting in undifferentiated chest pain assessment.","volume":"9","author":"Chew","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"zoi241116r17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/CIRCULATIONAHA.119.042960","article-title":"High-sensitivity cardiac troponin and the universal definition of myocardial infarction.","volume":"141","author":"Chapman","year":"2020","journal-title":"Circulation"},{"key":"zoi241116r18","first-page":"1","article-title":"COVID-19 Australia: Epidemiology Report 56: Reporting period ending 5 December 2021.","volume":"45","author":"COVID-19 National Incident Room Surveillance Team","year":"2021","journal-title":"Commun Dis Intell (2018)"},{"issue":"10","key":"zoi241116r19","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.mayocp.2021.07.002","article-title":"Thromboembolic risk in hospitalized and nonhospitalized COVID-19 patients: a self-controlled case series analysis of a nationwide cohort.","volume":"96","author":"Ho","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"zoi241116r20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China.","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"18","key":"zoi241116r21","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19.","volume":"76","author":"Piazza","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"zoi241116r22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"12","key":"zoi241116r23","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","article-title":"Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury.","volume":"137","author":"Chapman","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"zoi241116r24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.119.043100","article-title":"Incidence, trends, and outcomes of type 2 myocardial infarction in a community cohort.","volume":"141","author":"Raphael","year":"2020","journal-title":"Circulation"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2824887\/nguyen_2024_oi_241116_1727980025.09745.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T15:17:18Z","timestamp":1729005438000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2824887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,15]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.38541","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,15]]}}}